Esther Güse

Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy

A. Wessely, Harald Knorr, B. Schuler-Thurner, 2024, Journal for ImmunoTherapy of Cancer.

Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms

V. Santini, B. Peruzzi, U. Oelschlaegel, 2024, Leukemia.